Compugen (CGEN) financial statements
Compugen reported revenue of $73M in fiscal 2025, up 78.3% a year over 9 years.
Net income was $35M and the operating margin 43.1%, against -8145.8% in 2016.
Free cash flow was $31M.
The diluted share count rose 84% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Compugen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $400,000 | — | $18M | — | $2M | $6M | $8M | $33M | $28M | $73M |
| Cost of revenue | $223,000 | — | $1M | — | $60,000 | $680,000 | $975,000 | $2M | $8M | $9M |
| Gross profit | $489,000 | — | $17M | — | $2M | $5M | $7M | $31M | $20M | $64M |
| Research and development | $25M | $29M | $30M | $20M | $23M | $29M | $31M | $34M | $25M | $23M |
| Selling, general and admin | $7M | $8M | $8M | $8M | $10M | $11M | $10M | $10M | $9M | $9M |
| Operating income | -$33M | -$37M | -$23M | -$29M | -$31M | -$35M | -$35M | -$13M | -$15M | $31M |
| Interest expense | $23,000 | $15,000 | $23,000 | $32,000 | $42,000 | $25,000 | $27,000 | $31,000 | $34,000 | $28,000 |
| Pre-tax income | -$31M | -$37M | -$23M | -$28M | -$30M | -$34M | -$34M | -$10M | -$10M | $35M |
| Income tax | $20,000 | — | — | -$722,000 | $0 | $0 | $58,000 | $9M | $5M | $54,000 |
| Net income | -$32M | -$37M | -$23M | -$27M | -$30M | -$34M | -$34M | -$19M | -$14M | $35M |
| EPS (diluted) | -$0.62 | -$0.72 | -$0.41 | -$0.43 | -$0.37 | -$0.41 | -$0.39 | -$0.21 | -$0.16 | $0.38 |
| Diluted shares | 51M | 51M | 55M | 64M | 80M | 84M | 87M | 88M | 90M | 94M |
| Gross margin | 122.2% | — | 94.2% | — | 97.0% | 88.7% | 87.0% | 94.0% | 71.5% | 87.3% |
| Operating margin | -8145.8% | — | -130.5% | — | -1574.8% | -584.6% | -471.7% | -38.8% | -53.4% | 43.1% |
| Net margin | -7876.5% | — | -127.0% | — | -1484.9% | -570.0% | -449.3% | -56.1% | -51.1% | 48.6% |
Balance sheet
Fiscal years, from Compugen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $10M | $25M | $6M | $9M | $7M | $8M | $11M | $26M | $42M | $100M |
| Receivables | — | — | — | — | $2M | — | $0 | $61M | $0 | — |
| Total current assets | $63M | $31M | $47M | $45M | $129M | $123M | $86M | $115M | $106M | $148M |
| Property, plant and equipment | $6M | $5M | $3M | $2M | $2M | $2M | $2M | $1M | $852,000 | $681,000 |
| Total assets | $71M | $39M | $53M | $54M | $138M | $132M | $94M | $121M | $115M | $157M |
| Total current liabilities | $5M | $6M | $10M | $7M | $11M | $17M | $12M | $26M | $20M | $23M |
| Total liabilities | $8M | $9M | $16M | $15M | $19M | $25M | $16M | $56M | $60M | $54M |
| Shareholders' equity | $64M | $29M | $37M | $38M | $120M | $107M | $78M | $66M | $55M | $103M |
| Net debt | -$10M | -$25M | -$6M | -$9M | -$7M | -$8M | -$11M | -$14M | -$18M | -$91M |
Cash flow
Fiscal years, from Compugen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$20M | -$31M | -$13M | -$28M | -$28M | -$23M | -$34M | -$36M | $50M | $32M |
| Capital spending | $3M | $385,000 | $158,000 | $155,000 | $166,000 | $292,000 | $477,000 | $172,000 | $118,000 | $306,000 |
| Free cash flow | -$22M | -$31M | -$13M | -$28M | -$28M | -$23M | -$35M | -$36M | $49M | $31M |
| Stock-based compensation | $3M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $3M | $2M |
| Free cash flow margin | -5604.5% | — | -75.6% | — | -1424.3% | -383.0% | -461.2% | -107.8% | 177.6% | 43.1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CGEN.
Open CGEN in InvestinglyQuestions
What was Compugen's revenue in 2025?
$73M in fiscal 2025, from its 10-K filing.
How much free cash flow does Compugen generate?
$31M in fiscal 2025 (operating cash flow minus capital spending).
From Compugen's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.